Pin Oak Investment Advisors’s Novartis NVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$196K Buy
1,253
+791
+171% +$119K 0.14% 114
2026
Q1
$71K Hold
462
0.05% 178
2025
Q4
$72K Hold
462
0.05% 177
2025
Q3
$59.2K Buy
462
+93
+25% +$11.3K 0.04% 193
2025
Q2
$41K Hold
369
0.03% 213
2025
Q1
$42K Hold
369
0.03% 203
2024
Q4
$42K Hold
369
0.04% 203
2024
Q3
$42K Sell
369
-80
-18% -$9.08K 0.04% 203
2024
Q2
$48K Buy
449
+139
+45% +$14K 0.05% 175
2024
Q1
$30K Hold
310
0.03% 225
2023
Q4
$31K Hold
310
0.03% 215
2023
Q3
$32K Buy
+310
New +$31.5K 0.04% 202
2023
Q2
Sell
-310
Closed -$29K 476
2023
Q1
$29K Hold
310
0.04% 201
2022
Q4
$28K Buy
310
+80
+35% +$6.74K 0.03% 189
2022
Q3
$17K Hold
230
0.02% 233
2022
Q2
$19K Hold
230
0.02% 244
2022
Q1
$20K Hold
230
0.02% 260
2021
Q4
$20K Sell
230
-172
-43% -$14.3K 0.02% 259
2021
Q3
$33K Sell
402
-35
-8% -$3.15K 0.04% 202
2021
Q2
$40K Hold
437
0.04% 172
2021
Q1
$37K Hold
437
0.03% 192
2020
Q4
$41K Hold
437
0.03% 199
2020
Q3
$38K Hold
437
0.04% 182
2020
Q2
$38K Hold
437
0.04% 180
2020
Q1
$36K Sell
437
-310
-41% -$27.7K 0.04% 181
2019
Q4
$71K Hold
747
0.06% 162
2019
Q3
$65K Hold
747
0.05% 173
2019
Q2
$68K Buy
747
+516
+223% +$43.7K 0.05% 176
2019
Q1
$20K Buy
231
+42
+22% +$3.37K 0.02% 254
2018
Q4
$15K Buy
+189
New +$14.7K 0.01% 279
2018
Q1
Sell
-115
Closed -$9K 433
2017
Q4
$9K Buy
+115
New +$8.68K 0.01% 341

Other funds holding NVS

Pin Oak Investment Advisors's NVS Position: Q2 2026 in Review

Pin Oak Investment Advisors increased its Novartis (NVS) stake by 171% in Q2 2026, buying an estimated $119K and bringing the position to 1,253 shares worth $196K. The position accounts for 0.14% of the portfolio, ranked #114.

Pin Oak Investment Advisors first reported a position in NVS in Q4 2017 and has held it in 31 quarters since. 1,611 funds tracked by Wall St. Rank hold NVS as of Q2 2026.

  • Pin Oak Investment Advisors held 1,253 shares of Novartis worth $196K as of Q2 2026.
  • Pin Oak Investment Advisors bought 791 Novartis shares in Q2 2026, an estimated $119K.
  • Novartis made up 0.14% of Pin Oak Investment Advisors's portfolio in Q2 2026, its #114 holding.
  • Pin Oak Investment Advisors first reported a position in Novartis in Q4 2017 and has held it in 31 quarters since.
  • 1,611 funds tracked by Wall St. Rank held Novartis as of Q2 2026.

Based on Pin Oak Investment Advisors's 13F filing for Q2 2026, filed 11 Aug 2026.